These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nonrevascularizable buttock claudication improved with Sildenafil: A case report. Omarjee L, Camarzana A, Henni S, Abraham P. Medicine (Baltimore); 2017 Feb; 96(8):e6186. PubMed ID: 28225505 [Abstract] [Full Text] [Related]
4. The efficacy of transcutaneous electrical nerve stimulation on the improvement of walking distance in patients with peripheral arterial disease with intermittent claudication: study protocol for a randomised controlled trial: the TENS-PAD study. Besnier F, Sénard JM, Grémeaux V, Riédel M, Garrigues D, Guiraud T, Labrunée M. Trials; 2017 Aug 10; 18(1):373. PubMed ID: 28797281 [Abstract] [Full Text] [Related]
5. A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease. Russell KS, Yates DP, Kramer CM, Feller A, Mahling P, Colin L, Clough T, Wang T, LaPerna L, Patel A, Lawall H, Shennak MM, Fulmer J, Nikol S, Smith WB, Müller OJ, Ratchford EV, Basson CT. Vasc Med; 2019 Oct 10; 24(5):414-421. PubMed ID: 31277561 [Abstract] [Full Text] [Related]
6. Moderate-pain versus pain-free exercise, walking capacity, and cardiovascular health in patients with peripheral artery disease. Novaković M, Krevel B, Rajkovič U, Vižintin Cuderman T, Janša Trontelj K, Fras Z, Jug B. J Vasc Surg; 2019 Jul 10; 70(1):148-156. PubMed ID: 30922760 [Abstract] [Full Text] [Related]
7. The addition of evolocumab to maximal tolerated statin therapy improves walking performance in patients with peripheral arterial disease and intermittent claudication (Evol-PAD study). Clavijo LC, Caro J, Choi J, Caro JA, Tun H, Rowe V, Kumar SR, Shavelle DM, Matthews RV. Cardiovasc Revasc Med; 2023 Oct 10; 55():1-5. PubMed ID: 37142533 [Abstract] [Full Text] [Related]
8. Acute mitochondrial antioxidant intake improves endothelial function, antioxidant enzyme activity, and exercise tolerance in patients with peripheral artery disease. Park SY, Pekas EJ, Headid RJ, Son WM, Wooden TK, Song J, Layec G, Yadav SK, Mishra PK, Pipinos II. Am J Physiol Heart Circ Physiol; 2020 Aug 01; 319(2):H456-H467. PubMed ID: 32706261 [Abstract] [Full Text] [Related]
9. Beet the Best? Woessner M, VanBruggen MD, Pieper CF, Sloane R, Kraus WE, Gow AJ, Allen JD. Circ Res; 2018 Aug 31; 123(6):654-659. PubMed ID: 29976553 [Abstract] [Full Text] [Related]
10. Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication. Lewis RJ, Connor JT, Teerlink JR, Murphy JR, Cooper LT, Hiatt WR, Brass EP. Trials; 2011 May 25; 12():134. PubMed ID: 21612611 [Abstract] [Full Text] [Related]
11. Remote ischaemic preconditioning in intermittent claudication. Delagarde H, Ouadraougo N, Grall S, Macchi L, Roy PM, Abraham P, Prunier F. Arch Cardiovasc Dis; 2015 Oct 25; 108(10):472-9. PubMed ID: 26071836 [Abstract] [Full Text] [Related]
12. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Ahimastos AA, Walker PJ, Askew C, Leicht A, Pappas E, Blombery P, Reid CM, Golledge J, Kingwell BA. JAMA; 2013 Feb 06; 309(5):453-60. PubMed ID: 23385271 [Abstract] [Full Text] [Related]
13. Association of monocyte tumor necrosis factor α expression and serum inflammatory biomarkers with walking impairment in peripheral artery disease. Pande RL, Brown J, Buck S, Redline W, Doyle J, Plutzky J, Creager MA. J Vasc Surg; 2015 Jan 06; 61(1):155-61. PubMed ID: 25095746 [Abstract] [Full Text] [Related]
14. A Randomized Controlled Trial of Allopurinol in Patients With Peripheral Arterial Disease. Robertson AJ, Struthers AD. Can J Cardiol; 2016 Feb 06; 32(2):190-6. PubMed ID: 26277090 [Abstract] [Full Text] [Related]
15. Association between calf muscle oxygen saturation with ambulatory function and quality of life in symptomatic patients with peripheral artery disease. Gardner AW, Montgomery PS, Wang M, Shen B. J Vasc Surg; 2020 Aug 06; 72(2):632-642. PubMed ID: 32081480 [Abstract] [Full Text] [Related]
16. Efficacy of ankle-foot orthoses on walking ability in peripheral artery disease. Mays RJ, Mays AA, Mizner RL. Vasc Med; 2019 Aug 06; 24(4):324-331. PubMed ID: 30924412 [Abstract] [Full Text] [Related]
17. Six-month combined aerobic and resistance exercise program enhances 6-minute walk test and physical fitness in people with peripheral arterial disease: A pilot study. Machado I, Ferreira J, Magalhães C, Sousa P, Dias L, Santarém D, Moreira H, Abrantes C. J Vasc Nurs; 2024 Sep 06; 42(3):145-153. PubMed ID: 39244325 [Abstract] [Full Text] [Related]
18. Effect of structured home-based exercise on walking ability in patients with peripheral arterial disease: a meta-analysis. Li Y, Li Z, Chang G, Wang M, Wu R, Wang S, Yao C. Ann Vasc Surg; 2015 Apr 06; 29(3):597-606. PubMed ID: 25449991 [Abstract] [Full Text] [Related]
19. The effect of supervised exercise therapy for intermittent claudication on lower limb lean mass. Vun SV, Miller MD, Delaney CL, Allan RB, Spark JI. J Vasc Surg; 2016 Dec 06; 64(6):1763-1769. PubMed ID: 27633168 [Abstract] [Full Text] [Related]
20. Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudication. Mohler ER, Gainer JL, Whitten K, Eraso LH, Thanaporn PK, Bauer T. Vasc Med; 2011 Oct 06; 16(5):346-53. PubMed ID: 22003000 [Abstract] [Full Text] [Related] Page: [Next] [New Search]